N/A N=45 Non-Invasive Reduction of Fat in the Inner Thighs
Body Fat Disorder
Primary: Percentage of Pre-Treatment Images Correctly Identified by Reviewers — 90.5 percentage of correct identifications
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=60 Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound
Treatment of Adipose Tissue in the Thighs
Primary: Clinical Improvement in Thigh Circumference — -1.22; -0.59 centimeter
N/A N=60 Non-Invasive Reduction of Abdominal Fat
Fat Reduction
Primary: Proportion of Pre-treatment Images Correctly Identified — 128 photos — p=<0.001
N/A N=39 Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat Reduction
Adipose Tissue Atrophy
Primary: Change in Aesthetic Appearance From Baseline — 0.97 score on a scale
N/A N=12 Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
Body Fat
Primary: Number of Participants Who's Abdominal Tissue Showed Necrosis or Inflammatory Immune Cell Response — 10; 0 Participants
N/A N=30 Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)
Fat Atrophy
Primary: Number of Before and After Photograph Sets Correctly Identified by Independent, Blinded Evaluators — 54 Photo sets
N/A N=72 Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method
Subcutaneous Adipose Tissue
Primary: Change in Waist Circumference 12 Weeks After Treatment as Compared to Baseline — -1.6; -.96; -1.4; -1.2 cm
N/A N=20 Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System
Laser Assisted Liposuction
Primary: Correct Identification of Before and After Photographs — 20 Participants
N/A N=175 Non-Invasive Cooling of Fat Cells
Reduction of Unwanted Fat
Primary: Percentage of Participants With Visible Improvement in Treated Area — 65.2; 82.8 percentage of participants
N/A N=35 CoolSculpting System
Body Fat Disorder
Primary: Percentage of Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer Panel — 75.0 % of images identified correctly
N/A N=9 Histological Study to Assess Safety and Efficacy of the TempSure Firm for Non-Invasive Lipolysis
Non-invasive Lipolysis
Primary: Histology of Biopsy — 2; 2 Participants
N/A N=75 Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.
Circumference Reduction of Abdomen
Primary: Evaluation of Change in Abdomen Circumference Using Tape Measurements in cm at the 3 Months Follow-up Visit Comparing to Baseline. — 89.5 CM
N/A N=19 Fat Layer Reduction in the Lateral Thighs Using CoolSculpting
Body Fat Disorder
Primary: Safety of the Zeltiq CoolSculpting System in the Outer Thighs — 8; 0 events
N/A N=60 Non-invasive Cooling of Subcutaneous Fat
Fat Disorder
Primary: Change in Fat Layer Thickness of the Treated Flank — -18.7; -22.6; -17.8; -17.5 percent fat layer change
N/A N=14 Fat Reduction in the Submandibular/Submental Area
Body Fat Disorder
Primary: Proportion of Accurately Identified Pre-Treatment Photos by a Panel of Blinded Independent Reviewers — 11 photos
N/A N=31 An Evaluation of the Effect of the Erchonia Laser for Non-invasive Reduction of Submental Fat
Weight Loss
Primary: Proportion of Accurately Identified Subject Pre- and Post-treatment Photographs by at Least Two of the Three Blinded Independent Evaluators. — 26 Participants
N/A N=39 Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss
Obesity · Body Weight · Fat Burn
Primary: Change in Body Fat Percentage — -1.7556; 0.280 Percentage of Body Fat — p=<0.01
N/A N=60 Subcutaneous Fat Reduction in the Submental Area
Body Fat Disorder
Primary: Safety of CoolScupting in the Submental Area — 4 incidence of device- and/or procedure AE
N/A N=15 Cryolipolysis for Jawline Contouring
Body Fat Disorder
Primary: Number of Participants With Unanticipated Adverse Device Effects (UADE) — 0 Participants with UADE reported
Phase 4 N=110 CoolSculpting® Elite for Non-Invasive Fat Reduction
Non-invasive Fat Reduction
Primary: Percentage of Participants With "Satisfied" or "Very Satisfied" on Item #1 for the CSQ (Cryolipolysis Satisfaction Questionnaire) - Midsection — 83.3 percentage of…
N/A N=28 Clinical Efficacy of Cryolipolysis on the Fat of Thigh in Korean Women
Lipolysis · Cryotherapy Effect
Primary: Change in Cross Sectional Area of Fat in Both Thighs — -420.25; -28.53 millimeters squares
N/A N=25 Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature
Body Fat Disorder
Primary: Safety of the Zeltiq System for Non-invasive Fat Reduction in Subjects With Greater Flank Curvature. — 0; 0 UADEs
N/A N=30 Clinical Evaluation of the Safety and Efficacy of a 1060 nm Diode Laser (Flanks)
Fat Atrophy
Primary: Change in the Percentage of Fat Thickness From Baseline to 12-weeks Post-treatment — -6.9 percentage of body fat
Phase 3 N=44 Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management
Overweight · Obese
Primary: Change in Waist Circumference — -2.3; -6.0; -4.0 cm — p=0.398
N/A N=22 Cryolipolysis and Subcision for Treatment of Cellulite
Cellulite
Primary: Blinded Rating of the Treatment Area (Cryolipolysis vs. Subcision) With the Best Cosmetic Appearance. — 22.22; 33.33; 44.44 Percentage of participants
N/A N=20 Evaluation of CoolSculpt Combining Venus Legacy Technology for Enhanced Results in Fat Reduction & Laxity of the Flanks
Adipose Tissue
Primary: General Improvement in Skin Laxity of the Flank Area — 1.1; 2.1 units on a scale — p=<0.01
Phase 4 N=16 Submental Study (Sequential Treatment Approach)
Body Fat Disorder
Primary: The Proportion of Subjects Who Have at Least a 1-grade Improvement on the Clinician Reported Submental Fat Rating Scale (CR-SMFRS) at the Final Follow-up Visit When…
N/A N=40 Feasibility Study of a Belt Applicator
Body Fat Disorder
Primary: Change in the Fat Layer of the Treated Area as Measured by Ultrasound The Change in Fat Layer Thickness in the Treated Outer Thigh — -0.25 cm
Phase 2 N=62 Phase 2 Study for the Treatment of Superficial Lipomas
Lipoma
Primary: Number of Participants With Adverse Events (AEs) — 12; 13; 14; 12 participants
N/A N=20 Study of Lipolysis of Visceral Reserve Fat Using Tecar Therapy.
Obesity, Visceral · Obesity; Endocrine
Primary: Visceral Fat Loss (cm3) — -628 cm3